Описание: Innate immunity in Type C Hepatitis.- Mechanisms of Interferon Action and Resistance: Lessons learned from cell cultures studies.- Immunological Parameters Determining the Outcome of Hepatitis C Virus Infection.- The Effects of Interferon-Alpha Therapy on Immune Response and Outcome.- Microbial Components Associated with HCV Disease Interfere with Response to Interferon-alpha/Ribavarin Treatment.- IFN-induced Effector Proteins and HCV Replication.- Treatment of Chronic Hepatitis C with Various Genotypes.- IFNs in HCV infection: Biological and Clinical Considerations.- Clinical application of IFN-based therapy for HCV.- HCV therapy in difficult-to-treat patients.- Effects of IFN-alpha/Ribavirin Treatment on HCV Disease and Related Progression.
Название: Hepatitis B & C Managemt & Treat ISBN: 1841840777 ISBN-13(EAN): 9781841840772 Издательство: Taylor&Francis Цена: 3514.00 р. Наличие на складе: Поставка под заказ.
Описание: This text covers Hepatitis B and C, though the focus is clearly on Hepatitis C
Автор: Ellis Название: Hepatitis B Vaccines in Clinical Practice ISBN: 0824787803 ISBN-13(EAN): 9780824787806 Издательство: Taylor&Francis Рейтинг: Цена: 53592.00 р. Наличие на складе: Есть у поставщика Поставка под заказ.
Описание: Presents recommendations for vaccination for pre- and post-exposure prophylaxis in various suitable target populations and groups. This book: discusses serological assays in the field; examines how the vaccine was tested in international clinical trials; and, reveals how the vaccine may prevent some forms of hepatocellular carcinoma.
Автор: Kamal, Sanaa M. Название: Hepatitis C in Developing Countries ISBN: 0128032332 ISBN-13(EAN): 9780128032336 Издательство: Elsevier Science Рейтинг: Цена: 13298.00 р. Наличие на складе: Поставка под заказ.
Описание:
Hepatitis C in Developing Countries: Current and Future Challenges explores the current state of HCV in several countries, including Africa, Asia and South America. It maintains a dedicated focus on the epidemiology, clinical patterns, virologic diversity, coinfections, natural history and progression, complications, and response to standard of care (SOC) pegylated interferon and ribavirin therapy of HCV with recommendations specific to middle and low income countries. Readers will find detailed information on the burden of HCV infection from a global health and economic perspective, along with data from multicenter trials on DAAs that have enrolled patients infected with HCV non-genotype 1.
Features coverage on the prevention of, or inhibition of, liver fibrosis, cirrhosis, and hepatocellular carcinoma
Presents data from trials on patients with diverse ethnic backgrounds and those infected with genotypes 3, 4, 5, 6
Addresses the epidemiology, modes of transmission, socio-political aspects, genotypes, and co-infections of Hepatitis C
ООО "Логосфера " Тел:+7(495) 980-12-10 www.logobook.ru
